2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2yl]-methylthio]benzimidazole 103577-40-8 99%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-02-21
Product Details
- Product Name2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2yl]-methylthio]benzimidazole
- CAS No.103577-40-8
- EINECS No.1533716-785-6
- MFC16H14F3N3OS
- MW353.36
- AppearanceCrystalline PowderWhite to Pale Orange
- Melting point 149-150°C
- density 1.41
- storage temp. Inert atmosphere,Store in freezer, under -20°C
- Boiling point 494.9±55.0 °C(Predicted)
Company Profile Introduction
Glyra Healthcare Private Limited is a Private company incorporated on 16 January 2018. It is classified as Non-government company and is registered at Registrar of Companies, Ahmedabad. Its authorized share capital is Rs. 100,000 and its paid up capital is Rs. 100,000. It's NIC code is 519 (which is part of its CIN). As per the NIC code, it is inolved in Other wholesale [Includes specialized wholesale not covered in any one of the previous categories and wholesale in a variety of goods without any particular specialization.].
Glyra Healthcare's Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31 March 2023.
Directors of Glyra Healthcare are BHAVESHKUMAR NATHANI RANCHHODBHAI and BHAVISHABEN BHAVESHKUMAR NATHANI.
Glyra Healthcare's Corporate Identification Number (CIN) is U51909GJ2018PTC100558 and its registration number is 100558. Users may contact Glyra Healthcare on its Email address - BHAVESH.NATHANI@GLYRAHEALTHCARE.COM. Registered address of Glyra Healthcare is 1137/1, MELDI ESTATE, NR. MELDI MATA TEMPLE, NR. RAILWAY CROSSING, , Gandhinagar, Gujarat, India - 382481.
Supplier other products
Recommended supplier
-
VIP1年
- SLS Pharmaceuticals Private Limited
- 103577-40-8 98%
- Inquiry
- 2024-03-13
-
VIP1年
- Cubane Pharmaceuticals LLP
- 103577-40-8 99%
- Inquiry
- 2024-02-08
-
VIP1年
- Ralington Pharma
- 103577-40-8 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2yl]-methylthio]benzimidazole 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Raising Sun Pharma
- 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2yl]-methylthio]benzimidazole 103577-40-8 98%
- Inquiry
- 2024-02-03
-
VIP1年
- Ultratech India Ltd
- 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2yl]-methylthio]benzimidazole 98%
- Inquiry
- 2024-01-20
-
VIP1年
- Lakshmi Farmachem
- 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2yl]-methylthio]benzimidazole 98%
- Inquiry
- 2024-01-11
-
VIP1年
- Integrin Life Sciences. Pvt. Ltd.
- 103577-40-8 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2yl]-methylthio]benzimidazole 99%
- Inquiry
- 2024-01-09
-
VIP1年
- Enal Drugs Pvt Ltd
- 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2yl]-methylthio]benzimidazole 98%
- Inquiry
- 2024-01-08
-
VIP1年
- Ions Pharma
- 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2yl]-methylthio]benzimidazole 98%
- Inquiry
- 2024-01-05
- Since:2020-02-01
- Address: 43/A, Meldi Estate, B/H. West Cost Pharmaceuticals ltd. Nr. Gota Over Bridge, Gota, Ahmedabad, Gujar